铂力特(688333) - 2021 Q3 - 季度财报

Financial Performance - The company's operating revenue for Q3 2021 was ¥95,284,590.67, representing a year-over-year increase of 40.94%[2] - Year-to-date operating revenue reached ¥238,818,991.32, showing an 80.86% increase compared to the same period last year[2] - The net profit attributable to shareholders for Q3 2021 was -¥41,150,283.31, with no applicable year-over-year comparison[2] - The net profit attributable to shareholders for the year-to-date period is -120.0045 million RMB, a decrease of 106.9225 million RMB compared to the same period last year[10] - The net profit attributable to shareholders after deducting non-recurring gains and losses for the current period is -43.5938 million RMB, a decrease of 33.5680 million RMB year-on-year[10] - The net profit for Q3 2021 was -120,004,495.14 RMB, compared to -13,082,037.15 RMB in Q3 2020, indicating a significant decline in profitability[21] - The total comprehensive income for Q3 2021 was -120,562,639.28 RMB, compared to -12,906,380.71 RMB in the same period last year, reflecting a worsening financial position[22] - The basic and diluted earnings per share for Q3 2021 were both -1.50 RMB, compared to -0.16 RMB in Q3 2020, showing a substantial decrease in earnings per share[22] Research and Development - The total R&D investment for Q3 2021 was ¥23,464,265.57, an increase of 38.25% year-over-year[4] - R&D investment accounted for 24.63% of operating revenue in Q3 2021, a decrease of 0.48 percentage points from the previous year[4] - The total R&D investment for the current period is 23.4643 million RMB, an increase of 6.4919 million RMB, reflecting the company's continued focus on R&D[10] - The total R&D investment for the year-to-date period is 73.3635 million RMB, an increase of 31.0153 million RMB compared to the same period last year[10] - The ratio of R&D investment to operating income for the current period is 24.63%, a decrease of 0.48 percentage points due to significant growth in operating income[11] - The ratio of R&D investment to operating income for the year-to-date period is 30.72%, a decrease of 1.35 percentage points compared to the same period last year[11] - Research and development expenses increased to ¥73,363,484.95 in 2021 from ¥42,348,177.71 in 2020, reflecting a growth of approximately 73.2%[20] Assets and Liabilities - The total assets at the end of the reporting period were ¥1,933,999,013.22, reflecting a 15.20% increase from the end of the previous year[4] - Current liabilities totaled ¥486,526,596.25, compared to ¥241,535,373.87 in the previous year, showing an increase of approximately 101.0%[18] - The company's cash and cash equivalents decreased to ¥133,680,434.58 from ¥241,344,727.60, a decline of about 44.8%[17] - Inventory levels surged to ¥388,411,608.42, up from ¥195,312,620.04, representing an increase of approximately 98.7%[17] - The company's total equity was ¥1,158,509,618.91, slightly down from ¥1,161,754,090.34 in the previous year, indicating a decrease of about 0.3%[19] - Total liabilities amounted to RMB 517,021,367.08, with current liabilities at RMB 241,535,373.87[28] - The company's total equity attributable to shareholders was RMB 1,161,754,090.34, indicating strong shareholder value[29] Cash Flow - The net cash flow from operating activities for the year-to-date period is -82.8517 million RMB, a decrease of 112.0506 million RMB year-on-year[10] - Cash flow from operating activities for the first nine months of 2021 was -82,851,733.09 RMB, a decline from 29,198,898.31 RMB in the same period of 2020[24] - Cash inflow from operating activities totaled 306,358,586.49 RMB in Q3 2021, compared to 290,577,432.33 RMB in Q3 2020, indicating a slight increase in cash inflow[24] - Cash outflow from operating activities was 389,210,319.58 RMB in Q3 2021, compared to 261,378,534.02 RMB in Q3 2020, highlighting increased operational expenses[24] - The net cash flow from investing activities was -116,788,249.19 RMB in Q3 2021, a decrease from 244,420,552.33 RMB in Q3 2020, indicating reduced investment returns[25] - Cash and cash equivalents at the end of Q3 2021 were 122,704,870.38 RMB, down from 408,650,404.99 RMB at the end of Q3 2020, reflecting a decrease in liquidity[25] - The company received 145,740,142.24 RMB from financing activities in Q3 2021, compared to 24,410,000.00 RMB in Q3 2020, indicating increased financing efforts[25] Operational Highlights - The company experienced a significant increase in revenue from 3D printing customized products and self-developed equipment due to expanded capacity and increased market promotion efforts[8] - Total operating revenue for the first three quarters of 2021 reached ¥238,818,991.32, a significant increase from ¥132,044,985.99 in the same period of 2020, representing an increase of approximately 80.5%[20] - Total operating costs for the first three quarters of 2021 were ¥387,877,714.00, compared to ¥162,431,610.51 in 2020, indicating a rise of about 138.5%[20] - The company reported a credit impairment loss of -4,655,813.89 RMB in Q3 2021, compared to -2,380,232.72 RMB in Q3 2020, suggesting worsening credit conditions[21]